Centurion site · Pretoria, Gauteng

A medicines plant, not a farm

One site. One standard. Every step from mother stock to sealed pallet takes place inside a controlled, documented pharmaceutical process under EU-GMP Part 1 certification.

Certification: EU-GMP Part 1
Regulator: SAHPRA licensed
Site: Centurion, Pretoria
Batch release: Qualified person

Site location · Knoppieslaagte, Centurion

152 London Lane, Knoppieslaagte, Centurion 0035

The site sits on the Knoppieslaagte smallholdings between the R114 and the R55, minutes from the N14 and the N1 Ben Schoeman, with direct freeway access to OR Tambo International for air freight. The satellite view below shows the site and its surroundings.

Process flow

Controlled propagation

Production begins from maintained mother stock held under controlled conditions, with documented identity and lineage for every plant that enters a batch. Nothing enters the flow without a record.

Hybrid greenhouse cultivation

Cultivation runs in a sealed, positive-pressure hybrid greenhouse envelope. Natural highveld light provides the photosynthetic load; screens, climate control and fertigation control the rest. Setpoints, alarms and excursions are logged continuously.

Personnel and material flow

Entry is through air-locks with gowning and shower protocol. Personnel, material and waste flows are separated by design so cross-contamination is prevented structurally rather than procedurally.

Harvest and controlled drying

Harvest moves directly into dedicated, environmentally controlled drying and curing rooms with monitored temperature, humidity and airflow. Drying curves are recorded per batch.

Hand finishing

Post-harvest finishing is performed by hand in a cleanroom environment. Mechanical trimming shears resin glands and drives off volatile terpenes; hand finishing preserves the intact structure that the specification depends on.

Analytical testing

Batches are sampled and tested against specification for identity, potency, microbiological limits, residual solvents where applicable, pesticide residues and heavy metals, with retained reference samples.

Packing under GMP

Primary and secondary packing take place in classified areas under reconciled, serialised control, with line clearance and in-process checks documented before and after every run.

Qualified-person release and GDP dispatch

No batch leaves the site until the batch record is reviewed and released. Dispatch is under GDP conditions with monitored transport and a documented chain of custody to the receiving licence holder.

Facility engineering

Contamination control by design

Positive-pressure envelope with monitored pressure cascade
Air-lock entry with gowning and shower protocol
Classified cleanrooms for finishing and packing
Automated blackout screens for photoperiod control
Validated, calibrated environmental monitoring with alarming
Separated personnel, material and waste routes
Controlled documentation, deviation logging and CAPA
Retained reference and retention samples per batch

Governance

Quality has authority over production

The quality function is independent of production and cannot be overruled by commercial pressure. Release decisions sit with quality alone. Deviations are recorded, investigated and closed with documented corrective and preventive action, and change control governs every modification to a validated process, area or system.

Compliance leadership is held by Melanie Bertus, Head of Compliance, working with the qualified-person function on batch review and release. Site operations are directed by David Stoltz, CFO and South African Plant Director.

Environmental control · Centurion site

Validated monitoring feed

Monitoring

Cultivation Zone Temperature

22.4°C

Monitored continuously against setpoint · 5 min cadence

Relative Humidity

55.3%

Positive-pressure envelope within alarm limits

Substrate Conductivity

1.8mS/cm

Soil-less substrate · dosing under recipe control

Fertigation Water pH

5.8pH

Treated feedwater, buffered and trended

Environmental parameters only. No output, yield, volume, potency or product information is published on this site.

Compliance notice

This website is corporate and manufacturing information intended for licensed businesses, healthcare professionals and prospective counterparties. It is not promotional material for a medicine, it is not directed at patients or the general public, and nothing on it constitutes medical advice or an offer to supply.

Medical cannabis is a prescription medicine. SafriCanna does not make therapeutic, efficacy or safety claims, does not name indications, and does not supply the public. Any product may only be obtained through a licensed distribution channel on the authorisation of a healthcare professional in the patient's jurisdiction.

Read the full compliance notice